Effectiveness of Routine Patient Cleansing with Chlorhexidine Gluconate for Infection Prevention in the Medical Intensive Care Unit

被引:130
作者
Popovich, Kyle J. [1 ,2 ]
Hota, Bala [1 ,2 ]
Hayes, Robert [2 ]
Weinstein, Robert A. [1 ,2 ]
Hayden, Mary K. [2 ]
机构
[1] John H Stroger Jr Hosp Cook Cty, Dept Med, Infect Dis Sect, Chicago, IL 60612 USA
[2] Rush Univ, Dept Med, Infect Dis Sect, Med Ctr, Chicago, IL 60612 USA
关键词
BLOOD-STREAM INFECTIONS; EFFICACY; SAFETY; REDUCE;
D O I
10.1086/605925
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BACKGROUND. Controlled studies that took place in medical intensive care units (MICUs) have demonstrated that bathing patients with chlorhexidine gluconate (CHG) can reduce skin colonization with potential pathogens and can lessen the risk of central venous catheter (CVC)-associated bloodstream infection (BSI). OBJECTIVE. To examine, without oversight of practice by research study staff, the effectiveness or real-world effect of patient cleansing with CHG on rates of CVC-associated BSI. DESIGN. In the fall of 2005, the MICU at Rush University Medical Center discontinued bathing patients daily with soap and water and substituted skin cleansing with no-rinse, 2% CHG-impregnated cloths. This change was a clinical management decision without research input. SETTING. A 21-bed MICU at Rush University Medical Center. PATIENTS. Patients hospitalized in the MICU during the period from September 2004 through October 2006. METHODS. In a pre-post study design, we gathered data from administrative and laboratory databases, infection control practitioner logs, and patient medical charts to compare rates of CVC-associated BSI and blood culture contamination between the baseline soap-and-water bathing period (September 2004-October 2005) and the CHG bathing period (November 2005-October 2006). Rates of secondary BSI, Clostridium difficile infection (CDI), ventilator-associated pneumonia (VAP), and urinary tract infection (UTI) served as control variables that were not expected to be affected by CHG bathing. RESULTS. Bathing with CHG was associated with a statistically significant decrease in the rate of CVC-associated BSI (from 5.31 to 0.69 cases per 1,000 CVC-days; P = .006) and in the rate of blood culture contamination (from 6.99 to 4.1 cases per 1,000 patient-days; P = .04). Rates of secondary BSI, CDI, VAP, and UTI did not change significantly. CONCLUSIONS. In our analysis of real-world practice, daily bathing of MICU patients with CHG was effective at reducing rates of CVC-associated BSI and blood culture contamination. Controlled studies are needed to determine whether these beneficial effects extend outside the MICU.
引用
收藏
页码:959 / 963
页数:5
相关论文
共 21 条
[1]  
Bekeris LG, 2005, ARCH PATHOL LAB MED, V129, P1222
[2]   Eliminating catheter-related bloodstream infections in the intensive care unit [J].
Berenholtz, SM ;
Pronovost, PJ ;
Lipsett, PA ;
Hobson, D ;
Earsing, K ;
Farley, JE ;
Milanovich, S ;
Garrett-Mayer, E ;
Winters, BD ;
Rubin, HR ;
Dorman, T ;
Perl, TM .
CRITICAL CARE MEDICINE, 2004, 32 (10) :2014-2020
[3]  
BLEASDALE S, 2005, P 45 INT C ANT AG CH, P226
[4]   Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients [J].
Bleasdale, Susan C. ;
Trick, William E. ;
Gonzalez, Ines M. ;
Lyles, Rosie D. ;
Hayden, Mary K. ;
Weinstein, Robert A. .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (19) :2073-2079
[5]   National healthcare safety network (NHSN) report, data summary for 2006, issued June 2007 [J].
Edwards, Jonathan R. ;
Peterson, Kelly D. ;
Andrus, Mary L. ;
Tolson, James S. ;
Goulding, Joy S. ;
Dudeck, Margaret A. ;
Mincey, Randy B. ;
Pollock, Daniel A. ;
Horan, Teresa C. .
AMERICAN JOURNAL OF INFECTION CONTROL, 2007, 35 (05) :290-301
[6]   CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988 [J].
GARNER, JS ;
JARVIS, WR ;
EMORI, TG ;
HORAN, TC ;
HUGHES, JM .
AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) :128-140
[7]   The use and interpretation of quasi-experimental studies in infectious diseases [J].
Harris, AD ;
Bradham, DD ;
Baumgarten, M ;
Zuckerman, IH ;
Fink, JC ;
Perencevich, EN .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (11) :1586-1591
[8]  
LIN MY, 2008, 18 ANN M SOC HEALTHC, P97
[9]   Topical antibacterial agents [J].
Lio, PA ;
Kaye, ET .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2004, 18 (03) :717-+
[10]  
MAKI D, 2006, 16 ANN SCI M SOC HEA, P104